Aug 24, 2021 3:30pm EDT Mydecine Innovations Group Announces Mailing of Management Information Circular and Provides Update on Spin-Out of U.S. Cannabis Assets
Aug 18, 2021 7:30am EDT Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School of Medicine
Aug 16, 2021 4:55pm EDT Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update
Jul 21, 2021 7:30am EDT Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds
Jun 24, 2021 7:30am EDT Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004
Jun 23, 2021 7:30am EDT Mydecine to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th
Jun 08, 2021 7:30am EDT Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms